Kaletra (Lopinavir/Ritonavir): Basics

Lopinavir + Ritonavir (Kaletra) (November 30, 2012)
To read PDF, click here.
From AIDS InfoNet
An Overview of Kaletra (Lopinavir/Ritonavir) (September 13, 2012)
From AIDSinfo
Kaletra (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
FAQs About Kaletra (Lopinavir/Ritonavir) (January 12, 2012)
From The Body's "Ask the Experts" Forums
Medication Guide for Kaletra (February 2011)
Created by the makers of Kaletra specifically for people with HIV. Includes a rundown of possible side effects, reasons why Kaletra may not be a good fit for everybody, meds to avoid while taking Kaletra, and tips on how to maximize the chances Kaletra will work well.
From Abbott Laboratories
Patient Information About Kaletra (Lopinavir/Ritonavir) Tablets and Oral Solution (PDF) (February 2011)
From Abbott Laboratories
Patient Frequently Asked Questions (2011)
Information about the new Kaletra (lopinavir/ritonavir) tablets.
From Abbott Laboratories
Kaletra (Lopinavir/Ritonavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Lopinavir (Kaletra) (August 15, 2006)
From AIDS Treatment Data Network
Kaletra (Lopinavir/Ritonavir) (November 2005)
To read PDF, click here.
From The Center for AIDS
Drug Interactions: Kaletra (August 2004)
From Project Inform
The Debate Over Kaletra (Lopinavir/Ritonavir) "Monotherapy" (August 2004)
From amfAR, The Foundation for AIDS Research
What Role, Kaletra? (Spring 2001)
To read PDF, click here.
In CRIA Update, from AIDS Community Research Initiative of America
Drug Fact Sheet: Lopinavir/Ritonavir (Kaletra) (December 2000)
To read PDF, click here.
In Research Initiative/Treatment Action!, from The Center for AIDS
Kaletra (ABT-378/r) Approved (September 22, 2000)
Details and information sources on Kaletra (lopinavir plus low-dose ritonavir), a newly approved protease inhibitor approved last week.
In AIDS Treatment News, from AIDS Treatment News
FDA Approves Kaletra for HIV Infection (September 15, 2000)
FDA issues accelerated approval for enhanced protease inhibitor.
From U.S. Food and Drug Administration
Lopinavir: The Most Potent Protease Inhibitor (Summer 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's App for iPhones
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.